The termini of viral genomic RNA and its complementary strand are important in the initiation of viral RNA replication, which probably involves both viral and cellular proteins. To detect the possible cellular proteins involved in the replication of mouse hepatitis virus RNA, we performed RNA-protein binding studies with RNAs representing both the 5' and 3' ends of the viral genomic RNA and the 3' end of the negative-strand complementary RNA. Gel-retardation assays showed that both the 5'-end-positive-and 3'-end-negative-strand RNA formed an RNA-protein complex with cellular proteins from the uninfected cells. UV cross-linking experiments further identified a 55-kDa protein bound to the 5' end of the positive-strand viral genomic RNA and two proteins 35 and 38 kDa in size bound to the 3' end of the negative-strand cRNA. The results of the competition assay confirmed the specificity of this RNA-protein binding. No proteins were found to bind to the 3' end of the viral genomic RNA under the same conditions. The binding site of the 55-kDa protein was mapped within the 56-nucleotide region from nucleotides 56 to 112 from the 5' end of the positive-strand RNA, and the 35-and 38-kDa proteins bound to the complementary region on the negative-strand RNA. The 38-kDa protein was detected only in DBT cells but was not detected in HeLa or COS cells, while the 35-kDa protein was found in all three cell types. The juxtaposition of the different cellular proteins on the complementary sites near the ends of the positive-and negative-strand RNAs suggests that these proteins may interact with each other and play a role in mouse hepatitis virus RNA replication.
Mouse hepatitis virus (MHV), a coronavirus prototype, contains a positive-sense single-stranded RNA genome 31 kb in size (16, 23) . In infected cells, the viral genomic RNA is transcribed into negative-strand RNA (25) , which in turn is used to transcribe seven to eight mRNAs. These mRNAs have a nested-set 3'-coterminal structure, and the 5' end of each mRNA contains a 60-to 70-nucleotide (nt) leader sequence, which is identical among all the mRNAs and genomic RNA (14, 15, 31) . It has been shown that the leader RNA is important for the regulation and initiation of transcription of subgenomic mRNAs (2, 14, 30) .
The RNA sequences required for the transcription of MHV subgenomic mRNAs include both the 5' end of the genomic RNA (i.e., the region containing the leader sequence) and the intergenic sequences (i.e., the transcription initiation sites of subgenomic mRNAs [14] ). The latter region requires as few as 8 core nt (11, 19) , but the sequence in the former region required for transcription has not been precisely characterized. The sequence required for the replication of the full-length genomic RNA has also been partially characterized; at least for a defective interfering RNA, more than 800 nt of the 5'-end sequence and 400 nt of the 3'-end sequence of the genomic RNA are required for RNA replication (17) . However, the protein composition of the transcription or replication machineries for viral RNA synthesis is largely unknown. Presumably, virus-specific RNA polymerase, which is encoded by gene 1 of the MHV genome (14) , is responsible for both the replication and transcription of MHV RNA. Because an antibody specific for the viral nucleocapsid protein inhibited RNA synthesis (4), the nucleocapsid protein may also be a component of the transcription or replication machinery. In view of the multiple functions required for viral RNA synthesis, it would not be surprising that some host cellular factors also participate in MHV RNA synthesis.
Studies with other positive-stranded RNA viruses indeed suggested the possible involvement of host cellular factors in viral RNA replication. For example, deletion mutants in the 5' end of Sindbis virus RNA often have different levels of viral RNA replication in chicken and mosquito cells, suggesting that host factors interact with this RNA region and affect viral RNA replication in different cells (22) . Several cellular proteins have been found to bind to the 3' end of the negative-strand RNA of the Sindbis virus genome (24) . The RNA-protein complex formed between cellular proteins and a mutant viral RNA which contains a lethal mutation had a longer half-life than that of the wild-type RNA-protein complex (24) , suggesting the functional significance of the RNA-protein binding. Also, in poliovirus, a cellular protein was found to bind to a cloverleaf structure, which is required for RNA replication, at the 5' end of RNA (1). The sequence or structure of the 5' end of viral genomic RNA is probably directly involved in the RNA synthesis of most of the positive-stranded RNA viruses. For example, sequences similar to the internal control regions 1 and 2 of tRNA genes are found in the 5' end of the genomic RNAs of brome mosaic virus and other plant viruses (26) . The internal control region 2-like sequence in brome mosaic virus RNA forms a stem-loop structure. Most surprisingly, mutations which disrupt this structure in the positive-strand RNA reduced positive-strand RNA synthesis dramatically, but mutations which disrupt only negative-strand structure did not A. significantly affect RNA synthesis (26) , suggesting that the stem-loop structure at the 5'-end-positive-strand RNA is a promoter for genomic positive-strand RNA synthesis. All of these findings suggest potential roles in RNA replication of the 5'-end-positive-and 3'-end-negative-strand RNAs and of cellular proteins interacting with these regions.
In this study, we found that several different cellular proteins bind specifically to the complementary sites on the positive and negative strands of the 5'-end untranslated region (UTR) of MHV RNA. Some of the proteins are conserved among different cell lines. The possible roles of these proteins in viral RNA replication are discussed.
MATERALS AND METHODS
Construction of plasmids. Plasmids pNX and pHN2 were used throughout this study to generate various RNA transcripts in vitro. These plasmids were derived from DE25/ BSSK, which contained the complete cDNA sequence of DIssE RNA (21) (Fig. IA) , and the remaining sequence was blunt ended with T4 DNA polymerase and self-ligated to obtain pNXI and pHN2, respectively. pNX1 contains 182 nt from the 5' end of DIssE cDNA, which is flanked by two T7 promoters at the 5' end and a T3 promoter at the 3' end (Fig.  IB) . It has 46 nt between the two T7 promoters and 43 nt of vector sequence downstream of the T3 promoter. Only the first T7 promoter was active in in vitro transcription reactions with T7 RNA polymerase (data not shown). pHN2 contains 90 nt from the 3' end of DIssE cDNA, which is flanked by T7 promoter and 46 nt of vector sequence at the 5' end, and a T3 promoter and 40 nt of vector sequence at the 3' end (Fig.  IC) .
In vitro RNA transcription. pNXI was linearized with Dral, BstNI, and NotI and transcribed with T7 RNA polymerase to yield 56(+)5', 112(+)5', and 182(+)5' RNA, respectively, which represent the 5' end UTR of MHV genomic RNA (Fig.  lB) . For the synthesis of negative-strand RNA, pNXI was linearized with BstNI, DraI, and Hindlll and transcribed with T3 RNA polymerase to generate 70(-)3', 126(-)3', and 182(-)3' RNA, respectively, which represent the 3' end of negative-strand RNA complementary to the 5' end of MHV genomic RNA (Fig. IB) . For synthesis of the 3' end of positive-strand RNA, pHN2 was linearized with XbaI and transcribed with T7 RNA polymerase to yield 90(+)3', which represents the 3' end of MHV genomic RNA including poly(A) (Fig. 1 C) . For synthesis of a nonspecific competitor, plasmid pTZ18U (U.S. Biochemicals) was linearized with PvuII and transcribed with T7 RNA polymerase to generate a 149-nt RNA, which represents cloning sites and internal sequences of the vector. In vitro transcriptions were performed under the previously described conditions (33) Preparation of cytoplasmic extracts. DBT (9), COS-7 (8), and HeLa cells were grown in 15-cm-diameter dishes to confluence. Cells were washed with cold phosphate-buffered saline (PBS), scraped off the plates, and centrifuged at 1,500 x g for 10 min at 4°C. The cell pellets were resuspended in cold PBS (4.0 x 107 cells per ml), stored at -80'C, and thawed just before the experiments. Cytoplasmic extracts were prepared by a previously described method (29) Gel-retardation assay of RNA-protein binding. The gelretardation assay was carried out essentially as described previously (12) 7 .5], 2 mM MgCl2, 0.1 mM EDTA, 3.8% glycerol, 2 mM dithiothreitol). In competition assays, different amounts of unlabeled RNAs were lyophilized in Eppendorf tubes, resuspended together with a fixed amount of cellular extracts in the binding buffer, and incubated at 30)C for it) min prior to the addition of 32P-labeled RNA. In all reaction mixtures, approximately 40 pg of 32P-labeled RNA was used. The RNA-cellular extract mixture was incubated at 30(C for 10 min, followed by the addition of heparin to a final concentration of 1 mg/ml, and further incubated for 10 min. The reaction mixture was then mixed with one-fifth volume of S x loading buffer (50%7c glycerol, 0.05% bromophenol blue, 0.05% xylene cyanol) and separated by electrophoresis on a 4% polyacrylamide gel made in 0.5 x TBE (45 mM Tris-borate, 1 mM EDTA)-5%/a glycerol.
The polyacrylamide gels had been preelectrophoresed at 200 V for 30 min prior to the loading of samples, and electrophoresis was performed at 200 V at room temperature until xylene cyanol reached a point one-third from the top of the gel.
UV cross-linking of RNA-protein complexes. The RNAprotein binding reaction was first carried out as described for the gel-retardation assay, except that the cell extracts were preincubated with yeast tRNA. Briefly, the cytoplasmic extracts from different cells were mixed with 10 pg of yeast tRNA and unlabeled competitor RNAs, if needed, in 20 [I of the binding buffer and incubated at 30°C for 10 min. Subsequently. 100 pg of 329P-labeled RNA was added and the reaction mixture was incubated for an additional 10 min. The reaction mixture was then irradiated with UV light (254 nm [UV Stratalinker 2400; Stratagene]) on ice at a 14-cm distance for 10 min. After irradiation, RNase A was added to a final concentration of I mg/ml, and the mixture was incubated for 30 min at 37°C, boiled for 3 min in the sample buffer (10% glycerol. 5% P-mercaptoethanol, 3Cc sodium dodecyl sulfate [SDS], 62.5 mM Tris-HCI [pH 6.8]), and electrophoresed on a 12.5% polyacrylamide gel containing 0.1% SDS (13) .
RESULTS
Binding of cellular proteins to MHV UTR RNA detected by gel-retardation assay. To determine whether any cellular proteins bind to the UTR of MHV RNA, we initially carried out gel-retardation assays of RNA-protein binding, using the cytoplasmic extracts from DBT cells and RNAs representing the 5' end of positive-strand viral genomic RNA, the 3' end of negative-strand cRNA, and the 3' end of positive-strand viral genomic RNA. The sizes of RNAs used ranged from 90 to 182 nt plus various lengths of the vector sequence (see Materials and Methods). The 5' end of negative-strand cRNA was not examined because of technical difficulty in plasmid construction and also because the 5' end of negative-strand RNA is not expected to play a significant role in viral RNA synthesis (see Discussion). The results showed that a distinct RNA-protein complex of slower electrophoretic mobility was formed between the DBT cellular extract and both the 182(+)5' and 182(-)3' RNAs (Fig. 2) . The amounts of the RNA-protein complexes increased when increasing amounts of the cellular extracts were used; correspondingly, the amounts of the free RNA probes decreased. In contrast, incubation of 90(+)3' RNA with cellular extracts yielded only diffuse radioactivity, but no distinct RNA-protein complexes were detected (Fig. 2) . The lack of protein binding to the 90(+)3' RNA was confirmed by UV cross-linking studies (described below). Both 182(-)3' and 90(+)3' RNA preparations consisted of several RNA bands in the absence of the cellular extracts. They most likely represented different conformers or multimers of the same RNA, because only a single species was detected when the RNA transcript was examined by electrophoresis in agarose gels containing 6 M urea (data not shown). The 182(+)5' RNA also consisted of a diffuse RNA band. This was likely also caused by RNA secondary structure, because it yielded a distinct band when analyzed by denaturing agarose gel electrophoresis (data not shown). Heparin, a negatively charged polymer, which had been reported to reduce nonspecific binding of proteins to RNA (5), was included in all of the RNA-protein binding assays. It did not affect the formation of the RNA-protein complex observed in this study.
To examine the specificity of binding of the cellular proteins to UTR MHV RNAs, unlabeled specific and nonspecific RNAs were used as competitors for protein binding (Fig. 3) . The results showed that, when increasing amounts of the unlabeled 182(+)5' or 182(-)3' RNAs were incubated with the cellular extracts prior to the addition of the 232P-labeled respective RNAs, the RNA-protein complexes formed by both 182(+)5' and 182(-)3' RNAs proportionally decreased; in contrast, the comparable amounts of tRNA or vector RNA did not reduce the amounts of the RNA-protein complexes formed (Fig. 3) . These results demonstrated that the binding of the cellular proteins to 182(+)5' and 182(-)3' RNAs was specific.
Identification of the bound cellular proteins by UV crosslinking. To identify the proteins which bound to the MHV UTR RNAs, 32P-labeled RNAs were cross-linked to cellular proteins by UV irradiation and digested with RNase, and then the proteins were identified by SDS-polyacrylamide gel electrophoresis (PAGE). As shown in Fig. 4 . 182(+)5' RNA cross-linked to a protein approximately 55 kDa in size (arrowhead), which increased in amount when increasing amounts of cellular extracts were used. The 29-kDa band was probably an RNA fragment resistant to RNase, because this band was present even in the sample without cellular extract, and its amount decreased with increasing amounts of cellular extract. By comparison, 182(-)3' RNA bound to two proteins of 35 and 38 kDa in size (Fig. 4, arrowheads) . In some gels, a faint band approximately 90 kDa in size could also be detected, and its binding was specifically inhibited by the unlabeled homologous RNA (data not shown). The 90-kDa protein may be an unstable protein, because it was detected only with fresh cellular extracts. Similar UV cross-linking studies were performed with 90(+)3' RNA; no proteins were detected (data not shown). This finding is consistent with the results of the gel-retardation assay (Fig. 2) .
To examine the specificity of UV cross-linking reactions, the unlabeled homologous RNAs were used as specific competitors, and RNA transcribed from plasmid pTZ18U was used as a nonspecific competitor. As shown in Fig. 5 , when increasing amounts of the specific competitors were used, the amounts of the 55-, 35-, and 38-kDa proteins cross-linked to both RNAs decreased proportionally; in contrast, comparable amounts of the vector pTZl8U RNA did not reduce the amounts of the cross-linked proteins (Fig. 5) . These data showed that the binding of 182(+)5' and 182(-)3' RNAs to these cellular proteins was specific. In contrast, the amount of the 29-kDa band was not reduced by either the specific or nonspecific competitor RNAs.
Mapping of the protein-binding sites on 182(+)5' and 182(-)3' RNAs. To localize the binding sites of the cellular proteins on the MHV UTR RNAs, truncated RNAs of different sizes were transcribed from the different DNA templates which had been digested at different restriction sites (Fig. 1) . The transcribed RNAs were cross-linked to the cellular proteins by UV irradiation and digested with RNase. As shown in Fig. 6A 182( -)3' RNA; in contrast, 70( -)3' was not cross-linked to those proteins (Fig. 6B) . These results indicated that the binding site of the 35-and 38-kDa proteins on the 3-endnegative-strand RNA are in the 56-nt region between nt 56 and 112 from the 3' end of the negative-strand RNA. This region represents the complementary region of the 55-kDa proteinbinding site on the positive-strand RNA (see Fig. 1 ). These RNAs also generated multiple RNase-resistant RNA frag- ments in the absence of cellular extracts; their amounts decreased when increasing amounts of cellular extracts were added. Thus, they are likely derived from the cross-linked RNA secondary structures. The results of UV cross-linking studies on both positive-and negative-strand RNAs thus indicated that at least three cellular proteins bind to the same site on the complementary strands near the 5' end of MHV genomic RNA. Binding of the 55-kDa protein to longer RNA transcripts. Because the RNA transcripts used in the experiments described above contained vector sequences and represented only a small fraction of the full-length MHV viral genomic RNA, it is possible that the conformation of these RNA transcripts is different from that of the full-length RNA molecules. Therefore, the RNA-binding proteins described above may not bind to the natural viral RNAs. To rule out this possibility, we used 681-nt and 1,182-nt transcripts of DE25 plasmid (20) , which contain only one extra G residuc at the 5' end of the positive-strand RNA transcripts, for UV crosslinking studies. Figure 7 shows that the 55-kDa protein was cross-linked to both RNAs. We conclude that this protein likely binds to the natural MHV viral RNA and that the vector sequences did not contribute to the protein binding. Furthermore, no other proteins were cross-linked to these two RNAs. Thus, within the nearly 1.2 kb of the 5' end of positive-strand RNA, only the 5'-end UTR is capable of binding cellular proteins.
UV cross-linking studies of 182(-)3' RNA with cellular extracts from different cell lines. For the binding studies described above, the cellular extracts from DBT cells were used, because these cells were highly susceptible to MHV infection (9) . To determine whether the proteins bound to MHV UTR RNAs are conserved among different cell lines, 182( -)3' RNA was also cross-linked to the cellular extracts derived from HeLa cells and COS-7 cells. As shown in Fig. 8 , the 35-kDa protein was detected in all three cell lines, whereas the 38-kDa protein was barely detectable in HeLa or COS-7 cell extracts. This result shows that the 38-kDa protein is not expressed, or is expressed in very small amounts, in these two cell lines, while the 35-kDa protein is expressed in all of the cell lines. 
DISCUSSION
In this report, we have shown that several cellular proteins of different sizes bind to the different strands of MHV RNAs in the region corresponding to the 5' end of positive-strand genomic RNA and the 3' end of negative-strand cRNAs. Interestingly, these proteins bind to the complementary sites of the same 56-nt region near the ends of both positive-and negative-strand RNAs. The nature and functions of these cellular proteins are still not clear; however, the fact that the binding sites of these proteins are located near the end of the viral genomic and cRNAs suggests that they may be involved in RNA replication or transcription, because RNA replication is expected to start from the ends of viral RNA, and the 5'-leader RNA has been shown to be involved in subgenomic mRNA transcription (14) . These cellular proteins on both genomic and complementary strands of viral RNA can potentially interact with virus-encoded RNA polymerase to form a replication or transcription complex. Such a complex is expected to cover the end of the positive-or negative-stranded RNAs, inasmuch as the Escherichia coli RNA polymerase, which has a molecular size close to the expected coding capacity of the MHV polymerase gene (14, 16) , has been shown to cover approximately 75 bp of template DNA (6, 32) . The finding that the 55-kDa protein is the only cellular protein bound to MHV RNA within the first 1.2 kb from the 5' end further suggests that these proteins are involved in the initiation of RNA synthesis. Because the binding sites of the cellular proteins on the positive-and negative-strand RNAs are complementary, it is possible that these proteins might interact with each other during certain stages of viral RNA synthesis. Potentially, these cellular proteins are all part of the RNA replication or transcription complexes.
It is interesting that no cellular proteins were found to bind to the 3' end of positive-strand genomic RNA. In MHVinfected cells, the incoming viral genomic RNA is expected to be replicated from the 3' end of positive-strand RNA into (24) . The 5'-UTR RNA of poliovirus was reported to be cross-linked to a 54-kDa cellular protein, which may be a common translation factor for viral and nonviral mRNAs (7) . Other cellular proteins with sizes of 48 and 38 kDa were also cross-linked to other sites on the 5'-UTR RNA and may be associated with specific poliovirus translation (7) . A 57-kDa cellular protein was found to cross-link to two sites in the internal ribosomal entry site on the 5'-UTR of foot-and-mouth-disease virus RNA (18) . Whether the 54-and 57-kDa cellular proteins, which bind to poliovirus and foot-and-mouth disease virus RNA, are related to the 55-kDa protein, which binds to MHV positive-strand RNA, is an interesting issue.
It is likely that the binding regions of the cellular proteins on MHV RNA (nt 56 to 112 from the 5' end) overlap the consensus UCUAA repeats (14, 15) at the 3' end of the leader sequence (nt 70 to 80). Because the UCUAA repeats are also present at the intergenic sites preceding the open reading frames of each subgenomic mRNA, these proteins may also bind to the intergenic regions, which serve as the transcription initiation sites. Preliminary data indeed indicate that this is the case (35) . Thus, these proteins may play some roles not only in the replication of viral genomic RNA, but also in the transcription of subgenomic mRNAs. In addition, the 55-kDa protein bound to the viral genomic RNA may also play a role in translational regulation, because its binding site precedes the first open reading frame in the viral genome.
All of the RNA transcripts used in this study contain some vector sequences, and some of them contain an extra T7 promoter sequence. However, among the 5'-end-positivestrand RNA fragments used, 56(+)5' RNA did not cross-link to the 55-kDa protein, although it contains the same vector and Similarly, among the 3'-end-negative-strand RNA fragments used, 70(-)3' RNA did not cross-link to the 35-and 38-kDa proteins although it contains the same vector sequences as those in 126( -)3' and 182( -)3' RNAs. Therefore, these extra sequences were not responsible for the specific bindings observed between the MHV UTR RNAs and the cellular proteins, and these cellular proteins likely bind to the full-length viral RNAs in the virus-infected cells.
The 35-kDa protein, which bound to the 3' end of negativestrand RNA, is present in all three of the cell lines studied. It has been shown that MHV can replicate in COS-7 cells after transfection of MHV genomic RNA, even though COS-7 cells are not naturally susceptible to MHV infection because of the lack of an MHV receptor (34 (Fig. 6A) . These bands likely represent RNA fragments with strong secondary structures. Thus, these findings suggest that cellular extracts contain some enzymatic activities, such as RNA helicases, which reduced the secondary structures of RNAs and rendered them sensitive to RNase digestion. RNA helicase activities in some proteins, such as eukaryotic initiation factor 4A (eIF-4A) (27, 28) , human p68 protein (10) , and RNA helicases from HeLa cell nuclear extracts (3), have previously been detected. Whether the proteins detected in this study have RNA helicase activities will require additional studies.
